Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
PALO ALTO, Calif., Nov. 3, 2010 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing and commercializing novel cell-based therapeutics and tools for use in stem...
-
PALO ALTO, Calif., Nov. 2, 2010 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that it has been awarded cash grants by the U.S. government totaling $977,917 for projects related to...
-
PALO ALTO, Calif., Oct. 28, 2010 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that it has initiated a second clinical trial of its HuCNS-SC® product candidate (purified human...
-
PALO ALTO, Calif., Oct. 7, 2010 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) today provided an update on its ongoing Phase I clinical trial in Pelizaeus-Merzbacher Disease (PMD), a fatal...
-
PALO ALTO, Calif., Aug. 31, 2010 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that its technology was recently used by independent researchers to achieve the first genetically...
-
PALO ALTO, Calif., Aug. 19, 2010 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today the publication of new preclinical data demonstrating that the Company's proprietary human neural...
-
PALO ALTO, Calif., Aug. 10, 2010 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing and commercializing novel stem cell therapeutics and tools for use in stem...
-
PALO ALTO, Calif., June 30, 2010 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that it has entered into an agreement to sell seven million shares of its common stock to Seaside 88,...
-
PALO ALTO, Calif., June 17, 2010 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that three of its scientists will make presentations at the International Society for Stem Cell...
-
PALO ALTO, Calif., June 10, 2010 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that newly published independent research demonstrates that its GS2-M™ cell culture media...